Biotech

Compumedics Limited (ASX:CMP) Initiating Research Report

🕔10/26/2015 9:21:40 AM

Compumedics Limited (ASX:CMP) is pleased to announce the release of an initiating research report by PAC partners.

Read Full Article▸

Erin Resources Ltd (ASX:ERI) (MGC Pharmaceuticals) CBD Skin Care Formula Completes Phase 1 Testing - Excellent Results

🕔10/21/2015 10:56:08 AM

Erin Resources Ltd (ASX:ERI) is pleased to provide investors an update on the development of MGC Pharmaceuticals' (MGC) new CBD based skin care formula for the effective relief for Psoriatic skin.

Read Full Article▸

Regeneus Ltd (ASX:RGS) Annual Report 2015 to Shareholders

🕔10/19/2015 10:16:33 AM

Regeneus Ltd (ASX:RGS) are pleased to provide the Company's Annual Report for 2015 to shareholders.

Read Full Article▸

Regeneus Ltd (ASX:RGS) Receives R&D Tax Incentive Refund of $3.4 Million

🕔10/13/2015 10:01:17 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today reported that it has received $3.4m from the Australian Government's Research and Development Tax Incentive Program for activities conducted during the 2015 financial year.

Read Full Article▸

Rhinomed Ltd (ASX:RNO) Annual Report to Shareholders

🕔9/30/2015 6:46:16 PM

Rhinomed Ltd (ASX:RNO) has launched two products into global markets during the financial year: launching our new sleep quality aid, Mute(TM) into the global sleep device market and a new generation Turbine(TM) sports product in response to feedback from users.

Read Full Article▸

Compumedics Limited (ASX:CMP) Additional $1M China Sleep Contract

🕔9/21/2015 11:55:00 AM

Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a new three-year contract for the distribution of Compumedics' sleep diagnostic and monitoring systems across provinces in and around Shanghai with one of its long-term distribution partners in China, ZhiNuo.

Read Full Article▸

Rhinomed Ltd (ASX:RNO) Raises $2.5m in Private Placement

🕔9/18/2015 10:05:57 AM

Rhinomed Limited (ASX:RNO) is pleased to announce today that it has raised a total of A$2.5m by a way of a placement of 78,125,000 fully paid ordinary shares at A$0.032 per shares with institutional, Sophisticated, and Offshore investors (placement).

Read Full Article▸